Sunshine Insurance Group

Sunshine Insurance Group, established in 2005 and based in Beijing, China, is a prominent provider of insurance products and services. The company operates through three main segments: life insurance, property and casualty insurance, and other businesses. Its life insurance segment, primarily through Sunshine Life, offers a variety of life insurance products. The property and casualty segment, which contributes the majority of the company's revenue, is represented by Sunshine P&C and Sunshine Surety, providing a comprehensive range of property and casualty insurance solutions. Additionally, the other businesses segment focuses on corporate management and asset management services. With a strong presence across China, Sunshine Insurance Group serves diverse customer needs through its extensive insurance offerings.

Rong He

Managing Director

Zhang Weigong

Founder

22 past transactions

Data Grand

Series C in 2022
Data Grand is a semantic analysis solution developer.

Grit Science

Series A in 2022
Grit Science is a gene therapeutics firm, that engages in the R&D of liver genes.

Zaihui

Series D in 2022
Zaihui is a SaaS-based company headquartered in China, established in 2015, that specializes in providing marketing automation solutions for local businesses. The platform focuses on member management and enhancing customer loyalty through a range of services, including intelligent precision marketing and customized marketing strategies supported by big data. Zaihui's offerings enable local merchants, particularly in the restaurant sector, to operate more efficiently by utilizing features such as QR code ordering, online payment, and comprehensive membership management. The company's solutions aim to empower small and medium-sized businesses by helping them develop unique branding and effectively engage their customer base.

ImmuneOnco

Series C in 2022
ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd. develops and commercializes novel cancer immunotherapy products. The company designs platforms to reverse cancer cell-induced immune inhibition and to eradicate cancer cells. It offers platforms harnessing two types of innate immune cells, macrophages and natural killer (NK) cells to fulfill the cancer-killing task. The company’s platforms include Target-Activated NK (TANK™) Cell Therapy, PD-1/PD-L1 antibody blockade assay platform, and Activating Macrophages. The company was founded in 2015 and is headquartered in Shanghai, China.

XuanZhu Pharma

Series B in 2021
Shandong Xuanzhu Pharmaceutical Technology Co., Ltd. is engaged in pharmaceutical research and development. The company conducts pharmacodynamics and pharmacokinetic analysis,a process in which it screens, designs and matches chemical compounds, analysing the effect of drugs on the human body and their absorption rates. The company is based in China.

Neurophth

Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

GeekBang

Series B in 2021
Geekbang Technology Ltd. offers information technology learning services. The company is based in Beijing, China.

Lepu Bio

Series B in 2020
Lepu Biotechnology Co., Ltd. is a China-based biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform that facilitates the discovery, development, and manufacturing of innovative drug candidates. The company's core offerings include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). These products have advanced into clinical stages I to III, highlighting the company's commitment to advancing cancer treatment through its proprietary technologies.

MabPlex

Series B in 2020
MabPlex International Ltd provides contract development and manufacturing of biopharmaceuticals including, monoclonal antibodies (mAbs), recombinant proteins, Antibody Drug Conjugates (ADCs) and bispecifics. It offers customized mammalian cell medium, cell banking, monoclonal antibodiy active pharmaceutical ingredient (API) manufacturing, and biologics and ADC fill and finish manufacturing. The company was founded in 2013 and is based in Yantai, China with an additional office in Fremont, California.

Huisuanzhang

Series C in 2020
Huisuanzhang is a financial services platform for Chinese integrated enterprises. It provides services to SMEs including accounting, business registration, business change, tax audit, tax agency, trademark Registration, and other professional and efficient integration of tax services. Based on the user's recognition and trust, as of September 2017, HuiZhuZheng has set up seven branches in Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin and Hangzhou. The service network covers more than 200 cities in China with more than 300 Regional service agencies, to provide financial services to more than 230,000 business users. With the help of cloud and mobile Internet technology, HuiZhuZheng aims at standardization, refinement and scale-up, establishing marketing system, obtaining customer system, accounting service system, channel system, training system, business support system, tax-related service system, value-added service System, and other eight major systems, to achieve operational platform for standard operation. With core strengths such as technology-driven, service-oriented and innovative operation mode, HPC continuously upgrades and upgrades on the basis of improving user experience and resolving user's pain points, and solves the needs of small and medium-sized enterprises in their life-cycle taxation and taxation services. Huisuanzhang was established in April 2015.

Sinoiov

Series B in 2019
SINOIOV is a data technology company that takes data as its core and uses artificial intelligence technology to help the road freight industry reduce costs and increase efficiency and provide comprehensive services for the road freight industry. Up to now, the company has accumulated rich experience in commercial vehicle networking operation management and service, and has established national vehicle networking industrial bases in Beijing and Chongqing, with more than 40 provincial branches covering the whole country

DeepWise

Series C in 2019
Beijing Deepwise Science And Technology Co., Ltd. develops an artificial intelligence (AI) based medical application software that provides clinical imaging analysis and clinical diagnostics. The company offers early screening and diagnosis of various malignant diseases. It serves to hospitals, medical centers, and third party imaging centers. The company was founded in 2017 and is based in Beijing, China.

eCheng

Series C in 2019
ECheng (e成) is a B2B SaaS platform that provides HR matching and resume screening for enterprises. Using machine learning, data mining, and NLP (natural language processing), the company categorizes resumes that best fit the job requirements of the client company. The company was launched in 2013 by industry veterans from Baidu, IBM, and Microsoft, serving multinational conglomerates as well as small and medium-sized companies.

Zhihu

Series E in 2018
Zhihu (知乎) is a Chinese socialized website for questions and answers. It differs from traditional online question and answer forums by enabling users to obtain information through questions that provoke the opinions and views from answerers as individuals. The number of registered users on Zhihu has surpassed 300,000 by the end of January 2012. Zhihu was founded in 2011.

Meican

Series D in 2018
Meican.com (美餐) is a platform and website focused on providing mobile ordering of foods, detailed take-out menus as well as personal and enterprise meal ordering services. It enables users choose meals by themselves from many cooperative restaurants and enjoy personalized delicacy. Meican.com also enables enterprises become efficient in terms of delivering orders as well as solving the problems of food classification and settlement so that they can focus on their core business. Meican.com has vast experience of product research and development and offline operation due to its professional team. Established in Jan. 2011, Meican.com covers four major cities like Beijing, Shanghai, Guangzhou and Shenzhen, and it owns more than 30,000 cooperative restaurants.

Carzone

Private Equity Round in 2018
Jiangsu Kangzhong Shiye Investment operates a retail chain, Carzone, that deals in and retails automotive post-market parts. The company was founded in 1995 and is based in Nanjing, China.

MEGVII

Series C in 2017
Incorporated in 2011, Megvii is committed to make greatest value for customers and the whole society with extraordinary technology. Megvii is an Artificial Intelligence company specialized in providing enterprises and developers with intelligent solutions and data services, and is dedicated to the mission of “Create machines that can see and think”. Based on its original deep learning system Brain++, Megvii seeks to build AI Engine, a core fundamental technology powering various AI application. It is leveraging on recognition, control, optimization and other algorithms to connect individuals, objects and scenarios, building a product platform of IoT OS. It is connecting standardized hardware like sensors, robots and personal devices with AI+IoT (AIoT), thus commercializing three application-oriented IoT brains on a large scale, namely, city brain, supply chain brain, and personal life brain. Megvii is building an operation system for the era of AIoT. Megvii is an AIoT solutions expert.

DoBe China

Series B in 2017
DoBe Group, founded in 2006 and based in Shanghai, China, focuses on the development and operation of cultural and creative industry clusters. The company serves as a professional development operator of creative office parks, offering a comfortable and personalized office environment for cultural and creative enterprises. In addition to real estate management, DoBe provides a range of services designed to support the growth of these enterprises, including entrepreneurial services, brand promotion, financial consulting, and business registration. By catering to the specific needs of its clients, DoBe Group aims to foster the comprehensive development of the cultural and creative industries in China.

QuantGroup

Series C in 2016
Founded in 2014, QuantGroup is a data-driven, open-form financial services platform with a vision of “To move the world with data” based on independent research and development and deep financial background. To provide diversified, scene-based, refined and customized intelligent marketing services and financial technology integration services for consumer scenes and financial institutions, providing efficient technical support for consumers to enjoy convenient staging services.

Orbiepharm

Series C in 2016
Developer of pharmaceuticals and diagnostic products designed for animal health. The company's products focus on pet health, including medical diseases, chronic diseases, and geriatric diseases, and the company is the only pet medicine and health industry chain group enterprise with R&D, production, sales, and terminal hospitals in China now, enabling the animals to have more efficient diagnosis and treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.